Levels of activated FXII in survivors of myocardial infarction - Association with circulating risk factors and extent of coronary artery disease

被引:76
作者
Kohler, HP [1 ]
Carter, AM [1 ]
Stickland, MH [1 ]
Grant, PJ [1 ]
机构
[1] Gen Infirm, Unit Mol Vasc Med, Leeds LS1 3EX, W Yorkshire, England
关键词
D O I
10.1055/s-0037-1614210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Little data is available regarding the activated form of factor XIIa (FXIIa) in survivors of myocardial infarction. 292 Caucasian patients characterised for extent of coronary atheroma by angiography and for a past history of myocardial infarction and 77 healthy controls were included in the study. To investigate the relationship between coronary artery disease, activated factor XII and other circulating factors, we studied levels of FXIIa, cholesterol, triglycerides, fasting insulin, fibrinogen, FVII:C, t-PA antigen and PAI-1 antigen. Factor XIIa levels were higher in all patients [2.5 (2.3-2.6) ng/ml] and in patients with a history of MI [2.6 (2.4-2.9) ng/ml] than in controls [1.9 (1.7-2.1) ng/ml], p < 0.0001. In patients, FXIIa levels positively correlated with FVII:C, BMI, cholesterol, insulin, PAI-I antigen, t-PA antigen and triglycerides. In controls FXIIa levels only correlated with PAI-1 antigen and triglycerides. FXIIa levels were strongly associated with extent of coronary stenosis: 2.8 (2.6-3.1) ng/ml and 2.6 (2.3-2.9 ng/ml) in those with 2 and 3 vessels stenosed compared to 2.1 (1.9-2.3) ng/ml in those with 0 vessel stenosed (p = 0.0004). Activated FXII relates to both extent of coronary atheroma and to a past history of myocardial infarction and clusters with features of insulin resistance.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 34 条
[1]  
CLARKE BJ, 1989, J BIOL CHEM, V264, P11497
[2]  
CLAUSS A, 1957, ACTA HAEMATOL, V17, P731
[3]   Measurement of activated factor XII in health and disease [J].
Coppola, R ;
Cristilli, P ;
Cugno, M ;
Ariens, RAS ;
Mari, D ;
Mannucci, PM .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (05) :530-535
[4]   An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma [J].
Ford, RP ;
Esnouf, MP ;
Burgess, AI ;
Sarphie, A .
JOURNAL OF IMMUNOASSAY, 1996, 17 (02) :119-131
[5]   YOUNG INFARCT PATIENTS WITH SINGLE-VESSEL OCCLUSION DO NOT HAVE AN UNDERLYING PROTHROMBOTIC STATE TO EXPLAIN THEIR CORONARY-OCCLUSION [J].
GERSHLICK, A ;
COURT, DS ;
MILLS, P ;
BALCON, R .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1992, 36 (01) :49-56
[6]  
GORDON EM, 1987, J LAB CLIN MED, V109, P409
[7]   INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION [J].
HAMSTEN, A ;
WIMAN, B ;
DEFAIRE, U ;
BLOMBACK, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) :1557-1563
[8]  
HAUERT J, 1989, BLOOD, V73, P994
[9]   FIBRINOGEN AND FACTOR-VII IN THE PREDICTION OF CORONARY RISK - RESULTS FROM THE PROCAM STUDY IN HEALTHY-MEN [J].
HEINRICH, J ;
BALLEISEN, L ;
SCHULTE, H ;
ASSMANN, G ;
VANDELOO, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (01) :54-59
[10]  
Heywood DM, 1996, THROMB HAEMOSTASIS, V75, P401